Answer
Riociguat should not be used during breastfeeding, and breastfeeding should be discontinued during treatment because serious adverse reactions in breastfed infants are possible; human breastfeeding data are unavailable, animal data indicate excretion into milk, and risk to the infant cannot be excluded.
Sources for this answer
- Adempas 0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg, 2.5 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 16Document updated
Sources checked